Week #7 Rockville/Bethesda/Chevy Chase Gazette Ad Campaign

Please visit the FDA Protest 5/30/08 page and help us spread the word. There is much that everyone can do to help raise awareness. Thanks. CareToLive

Read/Download Richard Wick Bethesda/Chevy Chase/Kensington Gazette Ad richardwickgazettead.pdf

Popularity: 31%

Week #6 Rockville/Bethesda/Chevy Chase Gazette Ad Campaign

Read/Download Richard Ripp Rockville Gazette Ad richardrippgazettecolor.pdf

Please visit the FDA Protest 5/30/08 page and help us spread the word. There is much that everyone can do to help raise awareness. Thanks. CareToLive

(click to enlarge)

Popularity: 37%

May 6 at 8AM
Keynote speaker: Janet Woodcock, MD, Deputy Commissioner, FDA, Director, Center for Drug Evaluation and Research (CDER)

http://www.temple.edu/pharmacy_qara/08agenda.htm

VISIT OUR RALLY PAGE FOR MAY 30, 2008 NATIONWIDE PROSTATE CANCER DEMONSTRATION DETAILS http://caretolive.com/rally/

We are also looking for a demonstration coordinator to organize outside of Michael Milken’s The Prostate Cancer Foundation in Santa Monica. They have sadly been silent regarding the Provenge delay and need a wake up call.

HOPE TO SEE YOU AT THE PROTEST!

Popularity: 35%

This weeks ad in the Chevy Chase / Bethesda / Kensington Gazette features a strong proponent for the approval of Provenge, Dr. Robert Rostock, Chairman of Oncology, Geisinger, South Wilkes Barre, PA; Chairman, Radiation Oncology, Wyoming Valley Health Care, and Chair, Institutional Review Board; former faculty member and specialist in immunology research, Johns Hopkins Hospital.

Read/download color ad caretolivedrbobbethesdachevygazette.pdf

Read/download black/white ad caretolivedrbobbethesdachevygazettebw.pdf

(click to enlarge)

Popularity: 36%

Care To Live is very saddened by the loss of member Stephen H. Study. It is over a year since Provenge was voted 17-0 safe and 13-4 substantial evidence of efficacy by an FDA panel of experts. We are continuing our efforts on behalf of our have many prostate cancer sufferers desperately awaiting the approval of Provenge before it is too late for them. Here is week #4 of our ad campaign. Come on FDA. APPROVE PROVENGE NOW!!!!

Week #4 Color Ad Read and Print caretoliverockvillegazette4ad-part-2web.pdf

Week #4 Black & White Ad Read and Print caretoliverockvillegazette4ad-part-2bw.pdf

Next week, Week #5, we will place our ad in the Chevy Chase/Bethesda Gazette as we continue to raise awareness throughout the Maryland area as to the debacle that took place at the FDA in Rockville.

Popularity: 34%

In response to the FOIA complaint filed by CTL motion that CDER just does not have the time and resources to locate and process the request.

ctlmemocontrastaykerry5pdf2.pdf

Way to go Kerry!! THANKS!

Popularity: 37%

We are hot on the trail of the miscreants that derailed Provenge, a safe and effective immunotherapy for prostate cancer, condemning 30,000 American men to death without hope, in order to reap windfall profits.

Ed Silverman of Pharmalot reports on the shenanigans. (click link)

They may have taken down the links but we have the Proquest Investments 2007 Scientific Advisory Committee on our CareToLive research page showing the connections to Howard Scher and Milken’s Prostate Cancer Foundation that claims they want faster cures, yet remained mum on the Provenge Debacle. 3 Congressment are now calling for a Congressional hearing.

See our prior blog on Michael Milken’s Prostate Cancer Foundation and The Proquest Investment Fund / Howard Scher /FDA Unholy Alliance.(click link)

CareToLive is asking the public to help get to the bottom of the Provenge debacle by joining Congressmen Mike Michaud of Maine, Dan Burton of Indiana, and Tim Ryan of Ohio, who are calling for a congressional hearing into what happened. Contact your elected officials to ask for a congressional hearing, visiting the CareToLive website, dig our blogs, and join in the battle.

30,000 American men will die each year (not to mention the rest of the world) without this safe and effective immunotherapy. 1 in 6 men will get prostate cancer int heir lifetime. The FDA’s delay of Provenge was unprecedented in a terminal disease with an overwhelmingly positive panel that showed survival advantages, where no other options exist. Only one treatment for prostate cancer has been approved in 42 years. Send a clear message to Congress, the dysfunctional FDA, Wall Street, and the Chemo Cartel that we want this nontoxic immunotherapy approved NOW! More than 10 years of trials have shown it increases survival. Some men are alive as long as 6 years.

CONGRESSIONAL LETTER ASKING FOR A HEARING  PDF (click here) Please fax this letter to your own congressional representatives and ask them to join this action. TIA
Continue Reading Proquest Tries to Cover Its Tracks over Scher Provenge Debacle »

Popularity: 35%

While Michael Milken and the Prostate Cancer Foundation are whooping it up at the ballgame, some men are sneaking off to have their testicles removed in hopes that it will stop their PSA from rising, and their lives from ending prematurely from late stage prostate cancer. 1 in 6 men will be diagnosed with prostate cancer in their lifetimes. Over 30,000 American men will die from prostate cancer this year. Only 1 very toxic drug has been approved for late stage pc in over 42 years.

Along came Dendreon’s Provenge, an Immunotherapy voted overwhelmingly safe and effective by the FDA’s panel of experts convened to review Provenge. Was there foul play afoot when the FDA decided to delay approval. Perhaps if our men put some extra pine tar on their bats, we could get some coverage of this story. You would think that the deaths of 15,000 men since the delay would be enough.

Note the Picture on the bottom — David Solit, Tommy Lasorda, Dr. Howard Soule, Dr. Howard Scher and Mike Milken join together in support of the PCF’s Home Run Challenge at the New York Mets vs. Anaheim Angels game on June 10th, 2005 (click link)

Why hasn’t Michael Milken and his Prostate Cancer Foundation stepped up to the plate and publicly voiced his disappointment and disapproval of the decision by the FDA to delay Provenge? Is Milken financially conflicted? The whole thing is permeating a stench in the world of financially conflicted advocacy groups. Continue Reading Michael Milken and the Prostate Cancer Foundation’s Foul Balls »

Popularity: 95%

On a night in early April, 2007, the temperature was hanging around 35 degrees outside. It was considered good sleeping weather on the East Coast. But a particular doctor could not sleep. He tossed. He turned. His mind was still rapidly busy with the activities from a few days ago.

He could still see his fellow panelists sitting around the table in that hotel room in Gaithersburg, Maryland. He tried his best to influence them, to show them the flaws in the medical treatment they were evaluating. He kept pointing them to trial design problems, failed endpoints, and survival that surely could not have come from the agent.

Then the doctor’s gut suddenly felt that guilt-wrenching churn. Novacea and ProQuest had just popped into his head. If those panelists persuade the FDA to approve Provenge, he is finished. “Oh, no,” he thought, “and Schering-Plough will back out of that deal. I have to do something.”

Dr. Howard Scher sprang out of bed and headed to another room.

Continue Reading Sleepless in Asentar »

Popularity: 96%

Download the Memorandum - Click here

CareToLive Attorney Kerry Donahue files on behalf of the men with terminal prostate cancer who are running out of hope and time as thet desperately seek Provenge. We need everybody’s help in calling attention to this grave situation. Please Leave your comments and digg it. TIA

P.S. Two fleets of buses are rolling around DC and Rockville with our “Get on the Bus Gus” Provenge Confidential ad campaign.

Popularity: 89%